Literature DB >> 28836176

Elevated hardness of peripheral gland on real-time elastography is an independent marker for high-risk prostate cancers.

Qi Zhang1, Jing Yao2, Yehua Cai2, Limin Zhang3, Yishuo Wu3, Jingyu Xiong4, Jun Shi4, Yuanyuan Wang5, Yi Wang2.   

Abstract

OBJECTIVES: To examine the role of quantitative real-time elastography (RTE) features on differentiation between high-risk prostate cancer (PCA) and non-high-risk prostatic diseases in the initial transperineal biopsy setting.
METHODS: We retrospectively included 103 patients with suspicious PCA who underwent both RTE and initial transperineal prostate biopsy. Patients were grouped into high-risk and non-high-risk categories according to the D'Amico's risk stratification. With computer assistance based on MATLAB programming, three features were extracted from RTE, i.e., the median hardness within peripheral gland (PG) (H med), the ratio of the median hardness within PG to that outside PG (H ratio), and the ratio of the hard area within PG to the total PG area (H ar). A multiple regression model incorporating an RTE feature, age, transrectal ultrasound finding, and prostate volume was used to identify markers for high-risk PCA.
RESULTS: Forty-seven patients (45.6%) were diagnosed with PCA and 34 (33.0%) were diagnosed with high-risk PCA. Three RTE features were all statistically higher in high-risk PCA than in non-high-risk diseases (p < 0.001), indicating that the PGs in high-risk PCA patients were harder than those in non-high-risk patients. A high H ratio, high age, and low prostate volume were found to be independent markers for PCAs (p < 0.05), among which the high H ratio was the only independent marker for high-risk PCAs (p = 0.012). When predicting high-risk PCAs, the multiple regression achieved an area under receiver operating characteristic curve of 0.755, sensitivity of 73.5%, and specificity of 71.0%.
CONCLUSIONS: The elevated hardness of PG identified high-risk PCA and served as an independent marker of high-risk PCA. As a non-invasive imaging modality, the RTE could be potentially used in routine clinical practice for the detection of high-risk PCA to decrease unnecessary biopsies and reduce overtreatment.

Entities:  

Keywords:  High-risk cancers; Prostate cancer (PCA); Real-time elastography (RTE); Tissue elasticity; Transperineal biopsy; Transrectal ultrasound (TRUS)

Mesh:

Substances:

Year:  2017        PMID: 28836176     DOI: 10.1007/s11547-017-0803-1

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  28 in total

1.  Incremental detection rate of prostate cancer by real-time elastography targeted biopsies in combination with a conventional 10-core biopsy in 1024 consecutive patients.

Authors:  Georg Salomon; Nils Drews; Philippe Autier; Ann Beckmann; Hans Heinzer; Jens Hansen; Uwe Michl; Thorsten Schlomm; Alex Haese; Thomas Steuber; Markus Graefen; Andreas Becker
Journal:  BJU Int       Date:  2014-02-14       Impact factor: 5.588

2.  Prediction of Significant Prostate Cancer at Prostate Biopsy and Per Core Detection Rate of Targeted and Systematic Biopsies Using Real-Time Shear Wave Elastography.

Authors:  Katharina Boehm; Lars Budäus; Pierre Tennstedt; Burkhard Beyer; Jonas Schiffmann; Alessandro Larcher; Kathrin Simonis; Markus Graefen; Dirk Beyersdorff; Georg Salomon
Journal:  Urol Int       Date:  2015-06-03       Impact factor: 2.089

Review 3.  WFUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography: Part 5. Prostate.

Authors:  Richard G Barr; David Cosgrove; Marko Brock; Vito Cantisani; Jean Michel Correas; Arnoud W Postema; Georg Salomon; Masakazu Tsutsumi; Hui-Xiong Xu; Christoph F Dietrich
Journal:  Ultrasound Med Biol       Date:  2016-08-25       Impact factor: 2.998

4.  A positive real-time elastography is an independent marker for detection of high-risk prostate cancers in the primary biopsy setting.

Authors:  Yngve Nygård; Svein A Haukaas; Ole J Halvorsen; Karsten Gravdal; Jannicke Frugård; Lars A Akslen; Christian Beisland
Journal:  BJU Int       Date:  2013-11-27       Impact factor: 5.588

5.  Prostate-cancer mortality at 11 years of follow-up.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Alvaro Páez; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Sigrid Carlsson; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Paula M Kujala; Bert G Blijenberg; Ulf-Hakan Stenman; Andreas Huber; Kimmo Taari; Matti Hakama; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2012-03-15       Impact factor: 91.245

6.  Sonoelastomics for Breast Tumor Classification: A Radiomics Approach with Clustering-Based Feature Selection on Sonoelastography.

Authors:  Qi Zhang; Yang Xiao; Jingfeng Suo; Jun Shi; Jinhua Yu; Yi Guo; Yuanyuan Wang; Hairong Zheng
Journal:  Ultrasound Med Biol       Date:  2017-02-21       Impact factor: 2.998

7.  Combination of real-time elastography and urine prostate cancer gene 3 (PCA3) detects more than 97% of significant prostate cancers.

Authors:  Yngve Nygård; Svein A Haukaas; Jo E R Waage; Ole J Halvorsen; Karsten Gravdal; Jannicke Frugård; Lars A Akslen; Christian Beisland
Journal:  Scand J Urol       Date:  2012-10-04       Impact factor: 1.612

8.  Real-time elastography for the diagnosis of prostate cancer: evaluation of elastographic moving images.

Authors:  Tomoaki Miyagawa; Masakazu Tsutsumi; Takeshi Matsumura; Natsui Kawazoe; Satoru Ishikawa; Tatsuro Shimokama; Naoto Miyanaga; Hideyuki Akaza
Journal:  Jpn J Clin Oncol       Date:  2009-04-09       Impact factor: 3.019

9.  Prostate cancer detection with real-time elastography using a bi-plane transducer: comparison with step section radical prostatectomy pathology.

Authors:  Yunkai Zhu; Yaqing Chen; Tingyue Qi; Jun Jiang; Jun Qi; Yongjiang Yu; Xiaohong Yao; Wenbin Guan
Journal:  World J Urol       Date:  2012-08-12       Impact factor: 4.226

10.  A positive Real-Time Elastography (RTE) combined with a Prostate Cancer Gene 3 (PCA3) score above 35 convey a high probability of intermediate- or high-risk prostate cancer in patient admitted for primary prostate biopsy.

Authors:  Yngve Nygård; Svein A Haukaas; Ole J Halvorsen; Karsten Gravdal; Jannicke Frugård; Lars A Akslen; Christian Beisland
Journal:  BMC Urol       Date:  2016-07-08       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.